12-MONTH STUDY OF HALOPERIDOL DECANOATE IN CHRONIC-SCHIZOPHRENIC PATIENTS

被引：24

作者：

GELDERS, YG ^{[1
]}

REYNTJENS, AJM ^{[1
]}

ASH, CW ^{[1
]}

AERTS, TJL ^{[1
]}

机构：

[1] MCNEIL PHARMACEUT,DEPT BIOSTAT,SPRING HOUSE,PA

来源：

INTERNATIONAL PHARMACOPSYCHIATRY | 1982年 / 17卷 / 04期

关键词：

D O I：

10.1159/000468581

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：247 / 254

页数：8

共 7 条

[1]

AYD FJ, 1978, J CLIN PSYCHIAT, V39, P807

[2]

AYD FJ, 1972, INT DRUG THER NEWSL, V1, P33

[3] INTRAMUSCULAR HALOPERIDOL DECANOATE FOR NEUROLEPTIC MAINTENANCE THERAPY - EFFICACY, DOSAGE SCHEDULE AND PLASMA-LEVELS - AN OPEN MULTI-CENTER STUDY [J].

DEBERDT, R ;

ELENS, P ;

BERGHMANS, W ;

HEYKANTS, J ;

WOESTENBORGHS, R ;

DRIESENS, F ;

REYNTJENS, A ;

VANWIJNGAARDEN, I .

ACTA PSYCHIATRICA SCANDINAVICA, 1980, 62 (04) :356-363

[4]

FORSMAN A, 1977, CURR THER RES CLIN E, V21, P396

[5]

OVERALL JE, 1962, PSYCHOL REP, V10, P799

[6] PHARMACOKINETICS OF HALOPERIDOL DECANOATE - A 2-YEAR FOLLOW-UP [J].

REYNTJENS, AJM ;

HEYKANTS, JJP ;

WOESTENBORGHS, RJH ;

GELDERS, YG ;

AERTS, TJL .

INTERNATIONAL PHARMACOPSYCHIATRY, 1982, 17 (04) :238-246

[7]

WOGGON B, 1977, PRAXIS, V66, P421

← 1 →